Dolutegravir Pharmacokinetics in the Genital Tract and Colorectum of HIV Negative Men After Single and Multiple Dosing

OBJECTIVES: To describe first dose and steady-state pharmacokinetics (PK) of dolutegravir (DTG) in blood plasma (BP), seminal fluid (SF), colorectal tissue (RT), and rectal mucosal fluid (RF) of healthy HIV negative men. DESIGN: A Phase 1, open label, PK study that enrolled 12 healthy men taking DTG...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Greener, Benjamin N, Patterson, Kristine B, Prince, Heather MA, Sykes, Craig, Adams, Jessica L, Dumond, Julie B, Shaheen, Nicholas J, Madanick, Ryan D, Dellon, Evan S, Cohen, Myron S, Kashuba, Angela DM
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804901/
https://ncbi.nlm.nih.gov/pubmed/23945251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31829ed7a4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi